REDUCING THE SIDE EFFECTS THROUGH STEROID-SPARING
HELPING STEROID REFRACTORY PATIENTS
ENHANCING STEROID TREATMENTS
Novel Improved CBD-based Treatments
DEVELOPING A TREATMENT HELPING SEVERE COVID19 PATIENTS
STERO Biotech’s business concept and development plan are based on promising preliminary data from a phase 2 clinical trial in Graft Versus Host Disease (GVHD) performed by its founders, showing that the use of CBD SIGNIFICANTLY REDUCES THE NEED OF STEROID TREATMENT while arresting or curing the disease and its complications. Furthermore, data from literature and our own research shows that CBD is well tolerated. …More Details →
STERO Biotechs aims to solve an unmet need by using Cannabidiol (CBD), a non-psychotropic component of Cannabis sativa, which has been shown to possess potent Immuno-modulatory and anti-inflammatory properties in various indications. Our results in the GVHD trial show that CBD administration either enhanced the therapeutic effect of steroids or reduced the steroid dosage while maintaining or improving the steroid’s original therapeutic effect. …More Details→
A patent named CANNABIDIOL FOR REDUCING A STEROID DOSE AND TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES was filed in May 2017 by STERO Biotech. The Patent was granted on August 2018.
The patent covers the use of CBD for enhancing the therapeutic effect of a steroid or for reducing its dose, and for reducing side effects associated with the steroid.
Over 130 diseases are included …More Details →